AnaptysBio, Inc. (ANAB)

66.77 +1.04 (+1.58%) USD  |  NASDAQ  |  May 01, 16:00
66.77 0.00 (0.00%) After-Hours: 16:43
More

AnaptysBio Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade